Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

NCT00003239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: Recombinant Interferon Alfa
DRUG: Cytarabine
DRUG: Omacetaxine Mepesuccinate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]